Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNP infusion after acute myocardial infarction
ACTRN12606000144516Phase 3Active, not recruiting
- Sponsor
- Health Research Council of New Zealand
- Start
- Mar 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of nesiritide in myocardial infarction (MI) (2 arms), sponsored by Health Research Council of New Zealand. Primary endpoints: Detailed echocardiographic assessment of systolic and diastolic function, Plasma cardiac natriuretic peptides and 8 more. Started Mar 2003; status: active, not recruiting.
02
Drugs
nesiritide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ACTRN12606000144516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000144516.